RecruitingNCT07095205
Brain imaging of nicotine and antidepressant pathways
About this title
Read the official source — NCT07095205Medication studyAges 18–65United StatesDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Stony BrookSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 3, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 14
- Sponsor
- Stony Brook University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07095205
- Official title
Show the full official title
Central Cholinergic Dysfunction in Depression: PET Imaging of a Novel Treatment Target With [18F]VAT to Assess the Antidepressant Effect of Nicotine
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Stony Brook
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Stony Brook University, a university.
Does this study involve medication?
Yes. The study involves medication, including Nicotine transdermal patch and PET Scan with [18F] VAT.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
